Activities of Biapenem against Mycobacterium tuberculosis in Macrophages and Mice
ConclusionBP/CL may provide a new option to clinically treat MDR tuberculosis.
Source: Biomedical and Environmental Sciences - Category: Biomedical Science Source Type: research
More News: Biomedical Science | Environmental Health | Levaquin | Multidrug Resistance | Tuberculosis